{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:43:12Z","timestamp":1760150592831,"version":"build-2065373602"},"reference-count":33,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Neisseria meningitidis (N. meningitidis) serogroup B (MenB) is the leading cause of invasive meningococcal disease worldwide. The pathogen has a wide range of virulence factors, which are potential vaccine components. Studying the genetic variability of antigens within a population, especially their long-term persistence, is necessary to develop new vaccines and predict the effectiveness of existing ones. The multicomponent 4CMenB vaccine (Bexsero), used since 2014, contains three major genome-derived recombinant proteins: factor H-binding protein (fHbp), Neisserial Heparin-Binding Antigen (NHBA) and Neisserial adhesin A (NadA). Here, we assessed the prevalence and sequence variations of these vaccine antigens in a panel of 5667 meningococcal isolates collected worldwide over the past 10 years and deposited in the PubMLST database. Using multiple amino acid sequence alignments and Random Forest Classifier machine learning methods, we estimated the potential strain coverage of fHbp and NHBA vaccine variants (51 and about 25%, respectively); the NadA antigen sequence was found in only 18% of MenB genomes analyzed, but cross-reactive variants were present in less than 1% of isolates. Based on our findings, we proposed various strategies to improve the 4CMenB vaccine and broaden the coverage of N. meningitidis strains.<\/jats:p>","DOI":"10.3390\/medsci11040076","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T04:12:56Z","timestamp":1701403976000},"page":"76","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years: Vaccine Efficacy Prognosis"],"prefix":"10.3390","volume":"11","author":[{"given":"Viktoriia Yu.","family":"Savitskaya","sequence":"first","affiliation":[{"name":"Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119991, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-813X","authenticated-orcid":false,"given":"Nina G.","family":"Dolinnaya","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119991, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0291-1354","authenticated-orcid":false,"given":"Vadim V.","family":"Strekalovskikh","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119234, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2307-2255","authenticated-orcid":false,"given":"Elizaveta S.","family":"Peskovatskova","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119234, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoriia G.","family":"Snyga","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119991, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim S.","family":"Trefilov","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119991, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2582-6226","authenticated-orcid":false,"given":"Mayya V.","family":"Monakhova","sequence":"additional","affiliation":[{"name":"Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119992, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena A.","family":"Kubareva","sequence":"additional","affiliation":[{"name":"Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119992, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-346-2_1","article-title":"Neisseria meningitidis: Biology, Microbiology, and Epidemiology","volume":"Volume 799","author":"Christodoulides","year":"2012","journal-title":"Neisseria meningitidis"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/1469-0691.12647","article-title":"Neisseria meningitidis; Clones, Carriage, and Disease","volume":"20","author":"Read","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1084\/jem.10.5.690","article-title":"An Analysis of Four Hundred Cases of Epidemic Meningitis Treated with the Anti-Meningitis Serum","volume":"10","author":"Flexner","year":"1908","journal-title":"J. Exp. Med."},{"key":"ref_4","first-page":"S28410","article-title":"Meningococcal Disease: Changes in Epidemiology and Prevention","volume":"237","author":"Tzeng","year":"2012","journal-title":"Clin. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9202-7_1","article-title":"An Overview of Neisseria meningitidis","volume":"Volume 1969","author":"Seib","year":"2019","journal-title":"Neisseria meningitidis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","article-title":"Prospects for Vaccine Prevention of Meningococcal Infection","volume":"19","author":"Harrison","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1128\/CMR.2.Suppl.S118","article-title":"Global Epidemiology of Meningococcal Disease","volume":"2","author":"Schwartz","year":"1989","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/14712598.2011.585965","article-title":"Recombinant Protein Meningococcal Serogroup B Vaccine Combined with Outer Membrane Vesicles","volume":"11","author":"Bai","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0970-0218.96085","article-title":"Protein Conjugate Polysaccharide Vaccines: Challenges in Development and Global Implementation","volume":"37","author":"Nair","year":"2012","journal-title":"Indian J. Community Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/erv.11.50","article-title":"New Frontiers in Meningococcal Vaccines","volume":"10","author":"Anderson","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.tim.2023.02.011","article-title":"Meningococcal Factor H-Binding Protein: Implications for Disease Susceptibility, Virulence, and Vaccines","volume":"31","author":"Yee","year":"2023","journal-title":"Trends Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41467-018-02827-7","article-title":"Crystal Structure Reveals Vaccine Elicited Bactericidal Human Antibody Targeting a Conserved Epitope on Meningococcal fHbp","volume":"9","author":"Beernink","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/infdis\/jit239","article-title":"Importance of Inhibition of Binding of Complement Factor H for Serum Bactericidal Antibody Responses to Meningococcal Factor H-Binding Protein Vaccines","volume":"208","author":"Konar","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/21645515.2017.1264750","article-title":"Meningococcal Serogroup B Vaccines: Estimating Breadth of Coverage","volume":"13","author":"Donald","year":"2017","journal-title":"Human Vaccin. Immunother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad Vaccine Coverage Predicted for a Bivalent Recombinant Factor H Binding Protein Based Vaccine to Prevent Serogroup B Meningococcal Disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A Universal Vaccine for Serogroup B Meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1365-3156.2012.03085.x","article-title":"Advances with Vaccination against Neisseria meningitidis: Advances with Vaccination against Neisseria meningitidis","volume":"17","author":"Borrow","year":"2012","journal-title":"Trop. Med. Inter. Health."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","article-title":"Open-Access Bacterial Population Genomics: BIGSdb Software, the PubMLST. Org Website and Their Applications","volume":"3","author":"Jolley","year":"2018","journal-title":"Wellcome Open Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1474-4422(23)00195-3","article-title":"Global, Regional, and National Burden of Meningitis and Its Aetiologies, 1990\u20132019: A Systematic Analysis for the Global Burden of Disease Study 2019","volume":"22","author":"Wunrow","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1016\/j.vaccine.2016.08.015","article-title":"Distribution of Bexsero\u00ae Antigen Sequence Types (BASTs) in Invasive Meningococcal Disease Isolates: Implications for Immunisation","volume":"34","author":"Brehony","year":"2016","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The New Multicomponent Vaccine against Meningococcal Serogroup B, 4CMenB: Immunological, Functional and Structural Characterization of the Antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/0006-3223(87)90094-1","article-title":"Pearson\u2019s Correlation Coefficient, p-Value, and Lithium Therapy","volume":"22","author":"Amdisen","year":"1987","journal-title":"Biol. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/IAI.00103-12","article-title":"Design of Meningococcal Factor H Binding Protein Mutant Vaccines That Do Not Bind Human Complement Factor H","volume":"80","author":"Pajon","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Veggi, D., Bianchi, F., Santini, L., Lo Surdo, P., Chesterman, C.C., Pansegrau, W., Bechi, N., Huang, Y., Masignani, V., and Pizza, M. (2020). 4CMenB Vaccine Induces Elite Cross-Protective Human Antibodies That Compete with Human Factor H for Binding to Meningococcal fHbp. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008882"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"12099","DOI":"10.1096\/fj.201900374R","article-title":"Cocrystal Structure of Meningococcal Factor H Binding Protein Variant 3 Reveals a New Crossprotective Epitope Recognized by Human mAb 1E6","volume":"33","author":"Bianchi","year":"2019","journal-title":"FASEB J."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Borghi, S., Antunes, A., Haag, A.F., Spinsanti, M., Brignoli, T., Ndoni, E., Scarlato, V., and Delany, I. (2022). Multilayer Regulation of Neisseria meningitidis NHBA at Physiologically Relevant Temperatures. Microorganisms, 10.","DOI":"10.3390\/microorganisms10040834"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Maritan, M., Veggi, D., Cozzi, R., Dello Iacono, L., Bartolini, E., Lo Surdo, P., Maruggi, G., Spraggon, G., Bottomley, M.J., and Malito, E. (2018). Structures of NHBA Elucidate a Broadly Conserved Epitope Identified by a Vaccine Induced Antibody. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0201922"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1016\/j.vaccine.2017.06.020","article-title":"The Role of Anti-NHba Antibody in Bactericidal Activity Elicited by the Meningococcal Serogroup B Vaccine, MenB-4C","volume":"35","author":"Partridge","year":"2017","journal-title":"Vaccine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"B64","DOI":"10.1016\/j.vaccine.2009.04.061","article-title":"Meningococcal Carriage and Disease\u2014Population Biology and Evolution","volume":"27","author":"Caugant","year":"2009","journal-title":"Vaccine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.micpath.2013.02.003","article-title":"Neisseria meningitidis Serogroup B Vaccine Development","volume":"57","author":"Caesar","year":"2013","journal-title":"Microb. Pathog."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/microbiolspec.VMBF-0005-2015","article-title":"Antigenic Variation in Bacterial Pathogens","volume":"4","author":"Palmer","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e00196-18","DOI":"10.1128\/mSphere.00196-18","article-title":"Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland","volume":"3","author":"Mulhall","year":"2018","journal-title":"mSphere."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/11\/4\/76\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:35:59Z","timestamp":1760132159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/11\/4\/76"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["medsci11040076"],"URL":"https:\/\/doi.org\/10.3390\/medsci11040076","relation":{},"ISSN":["2076-3271"],"issn-type":[{"type":"electronic","value":"2076-3271"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}